Trial Outcomes & Findings for Clinical Evaluation of a 1060 nm Diode Laser, PEMF and Vacuum Assisted MP RF for Non-invasive Fat Reduction (NCT NCT04012814)
NCT ID: NCT04012814
Last Updated: 2024-04-23
Results Overview
Photographic evaluation by an independent, blinded reviewer with correct identification of pre-treatment baseline images when compared to post-treatment images taken at Week 24 using the Global Aesthetic Improvement Scale (GAIS). A score of 0 is no change, 1 - slight change, 2 - moderate change, 3 - dramatic change. An incorrect identification would result in a negative score (-1 for slight, -2 for moderate and -3 for dramatic change)
COMPLETED
NA
39 participants
Week 24
2024-04-23
Participant Flow
Participant milestones
| Measure |
Subject Treatment Group
Treatment group received 3 diode treatments and 3 RF/PEMF treatments at Week 0, 8 and 16.
Venus Bliss: The FDA-cleared device (Venus Bliss™) is a non-invasive medical aesthetic device designed for body contouring. The device is comprised of a console, and four 1060 nm diode laser applicators (60 mm x 60 mm). A belt is included to allow the operator to secure the laser applicators on the lipolysis treatment area, allowing hands-free operation. The device uses vacuum-assisted radiofrequency (RF) and PEMF (pulsed electromagnetic field) technology which has been shown in clinical studies to be safe and effective in body circumferential reduction and skin tightening.
|
|---|---|
|
Overall Study
STARTED
|
39
|
|
Overall Study
COMPLETED
|
31
|
|
Overall Study
NOT COMPLETED
|
8
|
Reasons for withdrawal
| Measure |
Subject Treatment Group
Treatment group received 3 diode treatments and 3 RF/PEMF treatments at Week 0, 8 and 16.
Venus Bliss: The FDA-cleared device (Venus Bliss™) is a non-invasive medical aesthetic device designed for body contouring. The device is comprised of a console, and four 1060 nm diode laser applicators (60 mm x 60 mm). A belt is included to allow the operator to secure the laser applicators on the lipolysis treatment area, allowing hands-free operation. The device uses vacuum-assisted radiofrequency (RF) and PEMF (pulsed electromagnetic field) technology which has been shown in clinical studies to be safe and effective in body circumferential reduction and skin tightening.
|
|---|---|
|
Overall Study
Lost to Follow-up
|
4
|
|
Overall Study
Withdrawal by Subject
|
2
|
|
Overall Study
Protocol Violation
|
1
|
|
Overall Study
Adverse Event
|
1
|
Baseline Characteristics
Clinical Evaluation of a 1060 nm Diode Laser, PEMF and Vacuum Assisted MP RF for Non-invasive Fat Reduction
Baseline characteristics by cohort
| Measure |
Subject Treatment Group
n=39 Participants
Treatment group received 3 diode treatments and 3 RF/PEMF treatments.
Venus Bliss: The FDA-cleared device (Venus Bliss™) is a non-invasive medical aesthetic device designed for body contouring. The device is comprised of a console, and four 1060 nm diode laser applicators (60 mm x 60 mm). A belt is included to allow the operator to secure the laser applicators on the lipolysis treatment area, allowing hands-free operation. The device uses vacuum-assisted radiofrequency (RF) and PEMF (pulsed electromagnetic field) technology which has been shown in clinical studies to be safe and effective in body circumferential reduction and skin tightening.
|
|---|---|
|
Age, Continuous
|
38.6 years
STANDARD_DEVIATION 11.1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
31 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
6 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
33 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
37 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Week 24Population: All subjects who had both Week 0 (baseline) and Week 24 (follow-up) photos.
Photographic evaluation by an independent, blinded reviewer with correct identification of pre-treatment baseline images when compared to post-treatment images taken at Week 24 using the Global Aesthetic Improvement Scale (GAIS). A score of 0 is no change, 1 - slight change, 2 - moderate change, 3 - dramatic change. An incorrect identification would result in a negative score (-1 for slight, -2 for moderate and -3 for dramatic change)
Outcome measures
| Measure |
Subject Treatment Group
n=31 Participants
Treatment group receiving 3 diode treatments and 3 RF/PEMF treatments at Week 0, 8 and 16 with a follow-up at Week 24.
Venus Bliss: The FDA cleared device (Venus Bliss™) is a non-invasive medical aesthetic device designed for body contouring. The device is comprised of a console, four 1060 nm diode laser applicators (60 mm x 60 mm). A belt is included to allow the operator to secure the laser applicators on the lipolysis treatment area, allowing hands free operation. The device uses vacuum assisted radiofrequency (RF) and PEMF (pulsed electromagnetic field) technology which has been shown in clinical studies to be safe and effective in body circumferential reduction and skin tightening.
|
|---|---|
|
Change in Aesthetic Appearance From Baseline
|
0.97 score on a scale
Standard Error 0.08
|
SECONDARY outcome
Timeframe: Week 24To assess subject satisfaction with treatment at the Week 24 visit using the 5-point Likert Subject Satisfaction Scale: 0 - very dissatisfied, 1 - dissatisfied, 2 - neutral, 3 - satisfied, 4 - very satisfied.
Outcome measures
| Measure |
Subject Treatment Group
n=31 Participants
Treatment group receiving 3 diode treatments and 3 RF/PEMF treatments at Week 0, 8 and 16 with a follow-up at Week 24.
Venus Bliss: The FDA cleared device (Venus Bliss™) is a non-invasive medical aesthetic device designed for body contouring. The device is comprised of a console, four 1060 nm diode laser applicators (60 mm x 60 mm). A belt is included to allow the operator to secure the laser applicators on the lipolysis treatment area, allowing hands free operation. The device uses vacuum assisted radiofrequency (RF) and PEMF (pulsed electromagnetic field) technology which has been shown in clinical studies to be safe and effective in body circumferential reduction and skin tightening.
|
|---|---|
|
Subject Satisfaction: 5-Point Likert Subject Satisfaction Scale
Satisfied (3)
|
11 Participants
|
|
Subject Satisfaction: 5-Point Likert Subject Satisfaction Scale
Neutral
|
9 Participants
|
|
Subject Satisfaction: 5-Point Likert Subject Satisfaction Scale
Dissatisfied
|
1 Participants
|
|
Subject Satisfaction: 5-Point Likert Subject Satisfaction Scale
Very Dissatisfied
|
0 Participants
|
|
Subject Satisfaction: 5-Point Likert Subject Satisfaction Scale
Very Satisfied (4)
|
10 Participants
|
SECONDARY outcome
Timeframe: Week 24Fat thickness was measured using ultrasound at one clinical site (14 subjects in total). Change between Week 0 and Week 24 measurements is shown.
Outcome measures
| Measure |
Subject Treatment Group
n=14 Participants
Treatment group receiving 3 diode treatments and 3 RF/PEMF treatments at Week 0, 8 and 16 with a follow-up at Week 24.
Venus Bliss: The FDA cleared device (Venus Bliss™) is a non-invasive medical aesthetic device designed for body contouring. The device is comprised of a console, four 1060 nm diode laser applicators (60 mm x 60 mm). A belt is included to allow the operator to secure the laser applicators on the lipolysis treatment area, allowing hands free operation. The device uses vacuum assisted radiofrequency (RF) and PEMF (pulsed electromagnetic field) technology which has been shown in clinical studies to be safe and effective in body circumferential reduction and skin tightening.
|
|---|---|
|
Change in Fat Thickness
|
-6.9 percentage of baseline
Standard Error 1.1
|
Adverse Events
Subject Treatment Group
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Subject Treatment Group
n=39 participants at risk
Treatment group received up to 3 diode treatments and up to 3 RF/PEMF treatments at Week 0, 8 and 16.
Venus Bliss: The FDA-cleared device (Venus Bliss™) is a non-invasive medical aesthetic device designed for body contouring. The device is comprised of a console, and four 1060 nm diode laser applicators (60 mm x 60 mm). A belt is included to allow the operator to secure the laser applicators on the lipolysis treatment area, allowing hands-free operation. The device uses vacuum-assisted radiofrequency (RF) and PEMF (pulsed electromagnetic field) technology which has been shown in clinical studies to be safe and effective in body circumferential reduction and skin tightening.
|
|---|---|
|
Skin and subcutaneous tissue disorders
Bruise
|
2.6%
1/39 • Number of events 1 • Up to the 24 week follow-up visit
|
|
Skin and subcutaneous tissue disorders
Temporary Nodule
|
15.4%
6/39 • Number of events 6 • Up to the 24 week follow-up visit
|
|
Skin and subcutaneous tissue disorders
Tenderness
|
2.6%
1/39 • Up to the 24 week follow-up visit
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place